Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm

참고문헌 (10)

1. Arnold M, "Global patterns and trends in colorectal cancer incidence and mortality", Gut, 66, pp.683~691 (2017)[DOI]
2. 이보인, "대장암 선별과 대장폴립 진단검사 가이드라인", Intestinal research, 10(1), pp.67~88 (2012), 대한장연구학회
3. Imperiale TF, "Multitarget stool DNA testing for colorectal-cancer screening", N Engl J Med, 370, pp.1287~1297 (2014)[DOI]
4. 박수경, "Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?", Intestinal research, 15(4), pp.495~501 (2017), 대한장연구학회
5. Church TR, "Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer", Gut, 63, pp.317~325 (2014)[DOI]
6. Oh T, "Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer", J Mol Diagn, 15, pp.498~507 (2013)[DOI]
7. Mitchell SM, "Evaluation of methylation biomarkers for detection of circulating tumor DNA and application to colorectal cancer", Genes (Basel), 7, pp.E125~ (2016)[DOI]
8. 박영숙, "Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm", Gut and Liver, 12(5), pp.508~515 (2018), 거트앤리버 소화기연관학회협의회
9. Oh TJ, "Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer", Clin Epigenetics, 9, pp.126~ (2017)[DOI]
10. Niu F, "Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia", Cancer Epidemiol Biomarkers Prev, 26, pp.1411~1419 (2017)[DOI]

관련 논문AI추천